Biology-Driven Cognitive Profiling in Huntington's Disease

Key facts

Sponsor

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Enrollment

90 enrolled

Eligibility

30-75 years · All sexes

Timeline

2021 – 2026

Study locations (1)

• Hospital de la Sant aCreu i Sant Pau, Barcelona, Spain

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Huntington's Disease

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE1NCT07246941
  A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RG6496 in Huntington's Disease
  Hoffmann-La Roche
• RECRUITINGNANCT06807892
  Comparison of Two Cognitive-Motor Rehabilitation Approaches Via Exergames: a Study of Cognitive, Motor and Behavioral Functions in Huntington's Disease Patients
  University Hospital, Angers
• RECRUITINGNANCT07299682
  Facilitating Effective Eating With DoddleBags: A Single-Arm Acceptability Study Of DoddleBags to Assess Impact on Self Feeding Behaviours in a Huntington's Disease Population
  University of Hull
• RECRUITINGPHASE1NCT06585449
  A Study to Evaluate ALN-HTT02 in Adult Patients With Huntington's Disease
  Alnylam Pharmaceuticals
• ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT04120493
  Safety and Proof-of-Concept (POC) Study With AMT-130 in Adults With Early Manifest Huntington's Disease
  UniQure Biopharma B.V.
• RECRUITINGNCT02855476
  HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease
  University College, London
• RECRUITINGNCT01574053
  Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
  CHDI Foundation, Inc.

See all trials for Huntington's Disease →